INTERPHARM
ActiveSummary
The computed 12-month bankruptcy probability of INTERPHARM is 4.3% (elevated). The 2025 annual accounts show negative equity (-€104,492) and a net result of -€3,030. Equity is shrinking by about 3.2% per year across the filed financial years. The company has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
18-09
NBB filing
Annual accounts filed
financial year 2025 · micro format · 49 days late
2025
29-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 29 days late
2024
23-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 23 days late
2023
14-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 14 days late
2022
14-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
02-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
25-08
NBB filing
Annual accounts filed
financial year 2019 · micro format · 25 days late
2019
12-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
26-09
NBB filing
Annual accounts filed
financial year 2017 · micro format · 57 days late
2017
25-08
NBB filing
Annual accounts filed
financial year 2016 · micro format · 25 days late
NBB filingOf the 22 annual accounts filed, the latest 10 are here; all 22 are at the National Bank.
1 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.